Increases in BMI and leptin concentrations were associated with a modest rate of reduction in PASI score, underlining the impact of obesity and metabolic dysfunction on treatment efficacy. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.